1. Metabolic oxidation phenotypes as markers for susceptibility to lung cancer.;Ayesh;Nature,1984
2. P53 and chromosone 3 abnormalities characteristic of malignant lung tumours are detectable in preinvasive lesions of the bronchus.;Sundaresan;Oncogene,1992
3. Genetic changes in premalignancy for cancer detection.;Sidransky;Lung Cancer,1994
4. Potentiation of cisplatin by alpha-interferon in advanced non-small cell lung cancer (NSCLC): a phase II study.;Bowman;Ann Oncol,1990
5. Cisplatin (CP) ± glutathione (GSH): a phase III, double-blind, randomized study in stage I-IV ovarian cancer [abstract].;Smyth;Ann Oncol,1994